| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. (SRPT) has 10 insiders with recent SEC Form 4 filings, including 7 buys and 6 sells. SRPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 659.8K | $13.17M | - | |
| Pres | 226.3K | $4.52M | - | |
| COO | 202.0K | $4.03M | - | |
| VP | 138.9K | $2.77M | - | |
| CFO | 135.1K | $2.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2023 | Wigzell Hans Lennart Rudolf60 | Director | Sale+OE | 15,000 | $106.72 | $1,600,800.00 | -41.7% | -26.2% | +36.7% | |
| Nov 17, 2022 | Mayo Stephen59 | Director | Sell | 858 | $109.92 | $94,311.36 | -11.8% | +13.4% | -24.4% | |
| Sep 14, 2022 | Chambers Michael Andrew56 | Director | Buy | 57,100 | $104.43 | $5,963,124.30 | +25.4% | +14.2% | +11.3% | |
| Aug 19, 2022 | Chambers Michael Andrew56 | Director | Buy | 46,170 | $108.28 | $4,999,230.00 | +92.5% | +1.9% | +3.7% | |
| Nov 24, 2021 | Rodino-Klapac Louise | Head Of R&D, CSO | Buy | 3,780 | $79.33 | $299,867.40 | +6.1% | -7.3% | +41.5% | |
| Nov 17, 2021 | Ingram Douglas S | President &CEO | Buy | 25,026 | $79.94 | $2,000,578.44 | +7.4% | +2.0% | +37.9% | |
| Mar 10, 2021 | Behrens M Kathleen | Director | Sale+OE | 5,000 | $85.76 | $428,800.00 | -3.7% | -7.3% | -4.2% | |
| Mar 8, 2021 | Wigzell Hans Lennart Rudolf60 | Director | Sale+OE | 10,000 | $83.51 | $835,100.00 | -37.7% | - | - | |
| Dec 11, 2020 | Bratica Joseph | Principal Financial Officer | Sale+OE | 1,115 | $165.00 | $183,975.00 | -12.0% | - | - | |
| Dec 8, 2020 | Bratica Joseph | Principal Financial Officer | Sale+OE | 1,125 | $160.00 | $180,000.00 | -12.1% | - | - |